Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Armolipid Plus and Metabolic Syndrome

This study has been completed.
Federico II University
Information provided by:
Rottapharm Identifier:
First received: March 12, 2010
Last updated: September 1, 2010
Last verified: September 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)